Key Drivers
- Strong Cash Flow
- Rising Leverage
- Thin Liquidity
AIAI Summary
HSIC is evolving from a low-margin distributor into a higher-productivity healthcare platform, with sustained gross-margin gains and BOLD+1 execution offering the clearest path to meaningful EPS upside; investors should favor the shares only if margin expansion persists across coming quarters, as leverage and buyback dependence leave little room for an operational setback.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Strong Cash Flow
- •Rising Leverage
- •Thin Liquidity
HSIC delivers stable margins and strong cash flow, but rising leverage, thin liquidity, and a premium valuation warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Downward trend
- •Critical support
- •Weak momentum
HSIC remains bearish over the last month, with a 4.1% decline below its $88.63 average; watch $84.84–$85.00 support for a rebound, while a break below it could extend losses unless shares reclaim $88.50–$89.00.
Sharp 6.6% decline from $90.86 on 2026-09-03 to $84.84 on 2026-09-18
Sentiment & News
Key News Insights:
- •Earnings Upgrade
- •Margin Expansion
- •Distribution Deal
Henry Schein's improving growth, margins, buybacks, and upgraded earnings outlook support a constructive near-term investment case.
The positive operational momentum and strategic partnership could strengthen HSIC's valuation and investor sentiment
Similar Companies in Healthcare
Other companies in the same sector with AI ratings